TABLE OF CONTENTS
Volume 27, Issue 17 (10 April 2008)
Original Articles
Immortalization of epithelial progenitor cells mediated by resveratrol
V P Pearce, J Sherrell, Z Lou, L Kopelovich, W E Wright and J W Shay
Oncogene 27: 2365-2374; advance online publication, October 29, 2007; doi:10.1038/sj.onc.1210886
Virus-mediated oncolysis induces danger signal and stimulates cytotoxic T-lymphocyte activity via proteasome activator upregulation
Y Endo, R Sakai, M Ouchi, H Onimatsu, M Hioki, S Kagawa, F Uno, Y Watanabe, Y Urata, N Tanaka and T Fujiwara
Oncogene 27: 2375-2381; advance online publication, November 5, 2007; doi:10.1038/sj.onc.1210884
Binding to nucleophosmin determines the localization of human and chicken ARF but not its impact on p53
S Moulin, S Llanos, S-H Kim and G Peters
Oncogene 27: 2382-2389; advance online publication, October 29, 2007; doi:10.1038/sj.onc.1210887
Protein kinase CK2 interacts with the splicing factor hPrp3p
S Lehnert, C Götz, S Kartarius, B Schäfer and M Montenarh
Oncogene 27: 2390-2400; advance online publication, November 19, 2007; doi:10.1038/sj.onc.1210882
COP1D, an alternatively spliced constitutive photomorphogenic-1 (COP1) product, stabilizes UV stress-induced c-Jun through inhibition of full-length COP1
M G Savio, G Rotondo, S Maglie, G Rossetti, J R Bender and R Pardi
Oncogene 27: 2401-2411; advance online publication, October 29, 2007; doi:10.1038/sj.onc.1210892
Differentially expressed genes are marked by histone 3 lysine 9 trimethylation in human cancer cells
J K Wiencke, S Zheng, Z Morrison and R-F Yeh
Oncogene 27: 2412-2421; advance online publication, October 29, 2007; doi:10.1038/sj.onc.1210895
Calcineurin-mediated dephosphorylation of c-Jun Ser-243 is required for c-Jun protein stability and cell transformation
C-C Huang, J-M Wang, U Kikkawa, H Mukai, M-R Shen, I Morita, B-K Chen and W-C Chang
Oncogene 27: 2422-2429; advance online publication, October 22, 2007; doi:10.1038/sj.onc.1210888
The p160 nuclear receptor co-activator RAC3 exerts an anti-apoptotic role through a cytoplasmatic action
G P Colo, M F Rubio, I M Nojek, S E Werbajh, P C Echeverría, C V Alvarado, V E Nahmod, M D Galigniana and M A Costas
Oncogene 27: 2430-2444; advance online publication, October 29, 2007; doi:10.1038/sj.onc.1210900
Hsp90 inhibition has opposing effects on wild-type and mutant p53 and induces p21 expression and cytotoxicity irrespective of p53/ATM status in chronic lymphocytic leukaemia cells
K Lin, N Rockliffe, G G Johnson, P D Sherrington and A R Pettitt
Oncogene 27: 2445-2455; advance online publication, November 5, 2007; doi:10.1038/sj.onc.1210893
Genome-wide SNP analysis of Tg.AC transgenic mice reveals an oncogenic collaboration between v-Ha-ras and Ink4a, which is absent in p53 deficiency
A Leder, J McMenamin, F Zhou, J L Moran, D R Beier and P Leder
Oncogene 27: 2456-2465; advance online publication, October 22, 2007; doi:10.1038/sj.onc.1210866
F-prostanoid receptor alters adhesion, morphology and migration of endometrial adenocarcinoma cells
K J Sales, S C Boddy and H N Jabbour
Oncogene 27: 2466-2477; advance online publication, October 29, 2007; doi:10.1038/sj.onc.1210883
A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion
S Tsutsumi, B Scroggins, F Koga, M-J Lee, J Trepel, S Felts, C Carreras and L Neckers
Oncogene 27: 2478-2487; advance online publication, October 29, 2007; doi:10.1038/sj.onc.1210897
Short Communications
Human APC sequesters 
-catenin even in the absence of GSK-3 in a Drosophila model
P R Rao, K Makhijani and L S Shashidhara
Oncogene 27: 2488-2493; advance online publication, October 29, 2007; doi:10.1038/sj.onc.1210890
MCAK associates with EB1
T Lee, K J Langford, J M Askham, A Brüning-Richardson and E E Morrison
Oncogene 27: 2494-2500; advance online publication, October 29, 2007; doi:10.1038/sj.onc.1210867
The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer
J Tommiska, J Bartkova, M Heinonen, L Hautala, O Kilpivaara, H Eerola, K Aittomäki, B Hofstetter, J Lukas, K von Smitten, C Blomqvist, A Ristimäki, P Heikkilä, J Bartek and H Nevanlinna
Oncogene 27: 2501-2506; advance online publication, November 5, 2007; doi:10.1038/sj.onc.1210885
Smad3 deficiency inhibits v-ras-induced transformation by suppression of JNK MAPK signaling and increased farnesyl transferase inhibition
P R Arany, S G Rane and A B Roberts
Oncogene 27: 2507-2512; advance online publication, October 22, 2007; doi:10.1038/sj.onc.1210889